abstract |
The invention relates to a pharmaceutical composition comprising CD4+ CD25+ regulatory T cells specific for at least one minor histocompatibility antigen, and also to stem cells, advantageously haematopoietic stem cells, carrying at least said antigen. Such a composition can be used as a medicament for increasing the immune tolerance of a histocompatible host. |